Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Alkaloids, Hydrogenated Ergot
2. Co-dergocrine
3. Dihydroergotoxin
4. Dihydroergotoxine
5. Ergot Alkaloids, Hydrogenated
6. Circanol
7. Co Dergine Mesylate
8. Co Dergocrine Mesilate
9. Co Dergocrine Mesylate
10. Co-dergine Mesylate
11. Co-dergocrine Mesilate
12. Co-dergocrine Mesylate
13. Dihydroergotoxine Mesylate
14. Dihydroergotoxine Methanesulfonate
15. Dihydroergotoxine Monomethanesulfonate
16. Ergodesit
17. Ergoloid Mesylate
18. Ergoloid Mesylates
19. Ergotoxin, Dihydro-, Monomethasulfonate
20. Hydergine
21. Methanesulfonate, Dihydroergotoxine
22. Monomethanesulfonate, Dihydroergotoxine
23. Redergam
24. Redergin
25. Redergine
1. Ergoloid Mesilates
2. Co-dergocrine Mesylate
3. Dihydroergotoxine Mesilate
4. Dihydrogenated Ergot Alkaloids
5. Chembl2311030
6. Dihydroergotoxine Methanesulfonate
| Molecular Weight | 2715.3 g/mol |
|---|---|
| Molecular Formula | C134H184N20O32S4 |
| Hydrogen Bond Donor Count | 16 |
| Hydrogen Bond Acceptor Count | 36 |
| Rotatable Bond Count | 19 |
| Exact Mass | 2714.2301933 g/mol |
| Monoisotopic Mass | 2713.2268385 g/mol |
| Topological Polar Surface Area | 724 Ų |
| Heavy Atom Count | 190 |
| Formal Charge | 0 |
| Complexity | 4690 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 28 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 8 |
| 1 of 2 | |
|---|---|
| Drug Name | Ergoloid mesylates |
| PubMed Health | Ergoloid Mesylates (By mouth) |
| Drug Classes | Antimigraine |
| Drug Label | Each tablet for oral use contains ergoloid mesylates USP; a mixture of the methanesulfonate salt of the following hydrogenated alkaloids:RDihydroergocornine-CH(CH ) 32Dihydroergocristine-CH C H 265Dihydro--ergocryptine-CH CH(CH ) 232Dihydro--ergo... |
| Active Ingredient | Ergoloid mesylates |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 1mg |
| Market Status | Prescription |
| Company | Mutual Pharm |
| 2 of 2 | |
|---|---|
| Drug Name | Ergoloid mesylates |
| PubMed Health | Ergoloid Mesylates (By mouth) |
| Drug Classes | Antimigraine |
| Drug Label | Each tablet for oral use contains ergoloid mesylates USP; a mixture of the methanesulfonate salt of the following hydrogenated alkaloids:RDihydroergocornine-CH(CH ) 32Dihydroergocristine-CH C H 265Dihydro--ergocryptine-CH CH(CH ) 232Dihydro--ergo... |
| Active Ingredient | Ergoloid mesylates |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 1mg |
| Market Status | Prescription |
| Company | Mutual Pharm |
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
67
PharmaCompass offers a list of Co-Dergocrine Mesilate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Co-Dergocrine Mesilate manufacturer or Co-Dergocrine Mesilate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Co-Dergocrine Mesilate manufacturer or Co-Dergocrine Mesilate supplier.
PharmaCompass also assists you with knowing the Co-Dergocrine Mesilate API Price utilized in the formulation of products. Co-Dergocrine Mesilate API Price is not always fixed or binding as the Co-Dergocrine Mesilate Price is obtained through a variety of data sources. The Co-Dergocrine Mesilate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A CODERGOCRINE MESILATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of CODERGOCRINE MESILATE, including repackagers and relabelers. The FDA regulates CODERGOCRINE MESILATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. CODERGOCRINE MESILATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A CODERGOCRINE MESILATE supplier is an individual or a company that provides CODERGOCRINE MESILATE active pharmaceutical ingredient (API) or CODERGOCRINE MESILATE finished formulations upon request. The CODERGOCRINE MESILATE suppliers may include CODERGOCRINE MESILATE API manufacturers, exporters, distributors and traders.
CODERGOCRINE MESILATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of CODERGOCRINE MESILATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right CODERGOCRINE MESILATE GMP manufacturer or CODERGOCRINE MESILATE GMP API supplier for your needs.
A CODERGOCRINE MESILATE CoA (Certificate of Analysis) is a formal document that attests to CODERGOCRINE MESILATE's compliance with CODERGOCRINE MESILATE specifications and serves as a tool for batch-level quality control.
CODERGOCRINE MESILATE CoA mostly includes findings from lab analyses of a specific batch. For each CODERGOCRINE MESILATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
CODERGOCRINE MESILATE may be tested according to a variety of international standards, such as European Pharmacopoeia (CODERGOCRINE MESILATE EP), CODERGOCRINE MESILATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (CODERGOCRINE MESILATE USP).
